Democrats circulate a new drug pricing outline with a big carveout for small biotechs

Politics Democrats circulate a new drug pricing outline with a big carveout for small biotechs By Lev Facher and Rachel Cohrs Nov. 2, 2021
Reprints
Rep. Frank Pallone (D-N.J.), chairman of a key House health care committee. J. Scott Applewhite/AP
W ASHINGTON — A proposed version of drug pricing legislation circulating among Capitol Hill aides and lobbyists includes an expansive carveout for small biotechnology companies and significantly waters down a provision to let Medicare negotiate drug prices, according to a draft obtained by STAT.
The new compromise would only allow the health secretary to negotiate the price of drugs …

Read the source article at statnews.com
2021-11-02 21:10:45